Markets › United States › NAS › NRIX

Nurix Therapeutics Inc

NAS:NRIXHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$25.81+3.53%LiveIn session · ≈ AED 94.79 · Market cap $2.82B · Next earnings Wed 17 Feb

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−273.1%	−291.4%	−377.6%	−145.7%	−306.3%	77.5%	—	—
Operating margin	−364.7%	−396.3%	−476.0%	−201.4%	−390.5%	−340.2%	−340.2%	+0.0 pts
Net margin	−242.7%	−393.9%	−466.9%	−187.0%	−354.9%	−314.9%	−314.9%	+0.0 pts
EBITDA margin	−352.4%	−386.8%	−456.2%	−179.0%	−339.7%	−291.5%	—	—
Return on equity	−14.9%	−34.2%	−59.4%	−71.8%	−36.7%	−49.1%	−49.1%	+0.0 pts
Return on assets	−10.9%	−24.6%	−43.3%	−40.5%	−28.9%	−38.4%	−38.4%	+0.0 pts
Return on capital employed	−18.5%	−28.7%	−53.1%	−57.7%	−37.1%	−47.5%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.2×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	0.0%	2.7%	2.9%	8.6%	4.2%	8.1%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	6.7×	4.7×	4.5×	3.4×	6.5×	7.0×	7.0×	+0.0%
Quick ratio	6.7×	4.7×	4.5×	3.4×	6.5×	7.0×	—	—
Cash ratio	2.7×	1.2×	0.9×	0.6×	1.1×	2.9×	2.9×	+0.0%
Asset turnover	0.0×	0.1×	0.1×	0.2×	0.1×	0.1×	—	—
Inventory turnover	—	—	−167.7×	—	—	—	—	—
Receivables turnover	1.6×	4.8×	35.1×	96.2×	36.4×	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—